Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.6800
-0.3600 (-34.62%)
May 9, 2025, 3:59 PM EDT
30.77%
Market Cap 51.24M
Revenue (ttm) n/a
Net Income (ttm) -3.41M
Shares Out 75.35M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,800
Average Volume 9,660
Open 0.6500
Previous Close 1.0400
Day's Range 0.6500 - 0.9500
52-Week Range 0.2800 - 1.2500
Beta 0.62
RSI 24.17
Earnings Date May 30, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It is developing respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.